Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Medicine, Weill Cornell Medical College, New York, New York.
Clin Cancer Res. 2023 Jan 4;29(1):165-173. doi: 10.1158/1078-0432.CCR-22-1254.
The gut microbiota is subject to multiple insults in allogeneic hematopoietic cell transplantation (allo-HCT) recipients. We hypothesized that preparative conditioning regimens contribute to microbiota perturbation in allo-HCT.
This was a retrospective study that evaluated the relationship between conditioning regimens exposure in 1,188 allo-HCT recipients and the gut microbiome. Stool samples collected from 20 days before transplantation up to 30 days after were profiled using 16S rRNA sequencing. Microbiota injury was quantified by changes in α-diversity.
We identified distinct patterns of microbiota injury that varied by conditioning regimen. Diversity loss was graded into three levels of conditioning-associated microbiota injury (CMBI) in a multivariable model that included antibiotic exposures. High-intensity regimens, such as total body irradiation (TBI)-thiotepa-cyclophosphamide, were associated with the greatest injury (CMBI III). In contrast, the nonmyeloablative regimen fludarabine-cyclophosphamide with low-dose TBI (Flu/Cy/TBI200) had a low-grade injury (CMBI I). The risk of acute GVHD correlated with CMBI degree. Pretransplant microbial compositions were best preserved with Flu/Cy/TBI200, whereas other regimens were associated with loss of commensal bacteria and expansion of Enterococcus.
Our findings support an interaction between conditioning at the regimen level and the extent of microbiota injury.
同种异体造血细胞移植(allo-HCT)受者的肠道微生物群受到多种因素的影响。我们假设预处理方案会导致 allo-HCT 中微生物群的紊乱。
这是一项回顾性研究,评估了 1188 例 allo-HCT 受者接受预处理方案暴露与肠道微生物组之间的关系。在移植前 20 天至移植后 30 天收集粪便样本,采用 16S rRNA 测序进行分析。通过α多样性的变化来量化微生物群损伤。
我们发现了不同的微生物群损伤模式,这些模式因预处理方案而异。在一个包含抗生素暴露的多变量模型中,将多样性损失分为三个等级的与预处理相关的微生物群损伤(CMBI)。高强度方案,如全身照射(TBI)-噻替哌-环磷酰胺,与最大的损伤(CMBI III)相关。相比之下,非清髓性方案氟达拉滨-环磷酰胺联合低剂量 TBI(Flu/Cy/TBI200)则损伤程度较低(CMBI I)。急性移植物抗宿主病的风险与 CMBI 程度相关。Flu/Cy/TBI200 可最大程度地保留移植前的微生物组成,而其他方案则与共生菌的丧失和肠球菌的扩张相关。
我们的发现支持方案水平的预处理与微生物群损伤程度之间的相互作用。